StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Appoints Matthew J. Pietras as CFO and COO

<< Previous

Bullboard Posts

Next >>

Comment by capebretongirlon Aug 04, 2021 9:42am

110 Views

Post# 33647618

RE:RE:RE:Appoints Matthew J. Pietras as CFO and COO

Bottom line is that we will need an infusion of clients seeking cancer diagnosis/treatment to replace the covid revenue which will dwindle away. Fresh thiking on the SZ board will not hurt this cause but revenue will determine the future of this company and right now its al about CARE and telehealth.